FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma
- PMID: 28592441
- DOI: 10.1136/gutjnl-2017-314138
FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma
Keywords: Advanced HCC; FOLFOX; HAIC.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Hepatocellular carcinoma: clinical frontiers and perspectives.Gut. 2014 May;63(5):844-55. doi: 10.1136/gutjnl-2013-306627. Epub 2014 Feb 14. Gut. 2014. PMID: 24531850 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical